186 related articles for article (PubMed ID: 11901094)
1. Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin.
Bolze S; Bromet N; Gay-Feutry C; Massiere F; Boulieu R; Hulot T
Drug Metab Dispos; 2002 Apr; 30(4):404-13. PubMed ID: 11901094
[TBL] [Abstract][Full Text] [Related]
2. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.
Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L
Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559
[TBL] [Abstract][Full Text] [Related]
3. A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements.
Wang J; Davis M; Li F; Azam F; Scatina J; Talaat R
Chem Res Toxicol; 2004 Sep; 17(9):1206-16. PubMed ID: 15377154
[TBL] [Abstract][Full Text] [Related]
4. Acyl glucuronide reactivity in perspective: biological consequences.
Bailey MJ; Dickinson RG
Chem Biol Interact; 2003 May; 145(2):117-37. PubMed ID: 12686489
[TBL] [Abstract][Full Text] [Related]
5. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
[TBL] [Abstract][Full Text] [Related]
6. A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides.
Zhong S; Jones R; Lu W; Schadt S; Ottaviani G
Drug Metab Dispos; 2015 Nov; 43(11):1711-7. PubMed ID: 26276581
[TBL] [Abstract][Full Text] [Related]
7. In vitro regioselective stability of beta-1-O- and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin.
Iwaki M; Ogiso T; Inagawa S; Kakehi K
J Pharm Sci; 1999 Jan; 88(1):52-7. PubMed ID: 9874702
[TBL] [Abstract][Full Text] [Related]
8. Acyl glucuronide metabolites: Implications for drug safety assessment.
Van Vleet TR; Liu H; Lee A; Blomme EAG
Toxicol Lett; 2017 Apr; 272():1-7. PubMed ID: 28286018
[TBL] [Abstract][Full Text] [Related]
9. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
Bailey MJ; Dickinson RG
Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
[TBL] [Abstract][Full Text] [Related]
10. Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.
Sawamura R; Okudaira N; Watanabe K; Murai T; Kobayashi Y; Tachibana M; Ohnuki T; Masuda K; Honma H; Kurihara A; Okazaki O
Drug Metab Dispos; 2010 Oct; 38(10):1857-64. PubMed ID: 20606003
[TBL] [Abstract][Full Text] [Related]
11. Safety Assessment of Acyl Glucuronides-A Simplified Paradigm.
Smith DA; Hammond T; Baillie TA
Drug Metab Dispos; 2018 Jun; 46(6):908-912. PubMed ID: 29559442
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of HT-29 colon adenocarcinoma cells by carboxylate NSAIDs and their acyl glucuronides.
Cannell GR; Vesey DA; Dickinson RG
Life Sci; 2001 Nov; 70(1):37-48. PubMed ID: 11764005
[TBL] [Abstract][Full Text] [Related]
13. Covalent binding of acidic drugs via reactive intermediates: detection of benoxaprofen and flunoxaprofen protein adducts in biological material.
Dahms M; Spahn-Langguth H
Pharmazie; 1996 Nov; 51(11):874-81. PubMed ID: 8985978
[TBL] [Abstract][Full Text] [Related]
14. Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes.
Harada H; Toyoda Y; Endo T; Kobayashi M
Pharmazie; 2015 Oct; 70(10):678-83. PubMed ID: 26601426
[TBL] [Abstract][Full Text] [Related]
15. In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids.
Georges H; Presle N; Buronfosse T; Fournel-Gigleux S; Netter P; Magdalou J; Lapicque F
Chirality; 2000 Feb; 12(2):53-62. PubMed ID: 10637410
[TBL] [Abstract][Full Text] [Related]
16. Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo.
Dong JQ; Liu J; Smith PC
Biochem Pharmacol; 2005 Sep; 70(6):937-48. PubMed ID: 16046212
[TBL] [Abstract][Full Text] [Related]
17. HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide.
Corcoran O; Mortensen RW; Hansen SH; Troke J; Nicholson JK
Chem Res Toxicol; 2001 Oct; 14(10):1363-70. PubMed ID: 11599927
[TBL] [Abstract][Full Text] [Related]
18. Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin.
Castillo M; Smith PC
Drug Metab Dispos; 1995 May; 23(5):566-72. PubMed ID: 7587932
[TBL] [Abstract][Full Text] [Related]
19. Acyl glucuronides: the good, the bad and the ugly.
Regan SL; Maggs JL; Hammond TG; Lambert C; Williams DP; Park BK
Biopharm Drug Dispos; 2010 Oct; 31(7):367-95. PubMed ID: 20830700
[TBL] [Abstract][Full Text] [Related]
20. Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites.
Li C; Benet LZ; Grillo MP
Chem Res Toxicol; 2002 Oct; 15(10):1309-17. PubMed ID: 12387630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
